356 related articles for article (PubMed ID: 21119115)
1. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
[TBL] [Abstract][Full Text] [Related]
2. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
[TBL] [Abstract][Full Text] [Related]
3. Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.
Wada T; Kanegane H; Ohta K; Katoh F; Imamura T; Nakazawa Y; Miyashita R; Hara J; Hamamoto K; Yang X; Filipovich AH; Marsh RA; Yachie A
Cytokine; 2014 Jan; 65(1):74-8. PubMed ID: 24084330
[TBL] [Abstract][Full Text] [Related]
4. SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.
Yang X; Miyawaki T; Kanegane H
Pediatr Int; 2012 Aug; 54(4):447-54. PubMed ID: 22672194
[TBL] [Abstract][Full Text] [Related]
5. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
Marsh RA; Bleesing JJ; Filipovich AH
J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
[TBL] [Abstract][Full Text] [Related]
6. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
Jin YY; Zhou W; Tian ZQ; Chen TX
Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
[TBL] [Abstract][Full Text] [Related]
7. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease.
Marsh RA; Madden L; Kitchen BJ; Mody R; McClimon B; Jordan MB; Bleesing JJ; Zhang K; Filipovich AH
Blood; 2010 Aug; 116(7):1079-82. PubMed ID: 20489057
[TBL] [Abstract][Full Text] [Related]
8. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome.
Sun J; Ying W; Liu D; Hui X; Yu Y; Wang J; Wang X
Scand J Immunol; 2013 Nov; 78(5):463-7. PubMed ID: 23944711
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of intracellular SH2D1A protein in cytotoxic lymphocytes from patients with X-linked lymphoproliferative disease and their family members.
Tabata Y; Villanueva J; Lee SM; Zhang K; Kanegane H; Miyawaki T; Sumegi J; Filipovich AH
Blood; 2005 Apr; 105(8):3066-71. PubMed ID: 15632210
[TBL] [Abstract][Full Text] [Related]
11. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
[TBL] [Abstract][Full Text] [Related]
12. X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India.
Jindal AK; Mondal S; Sil A; Rawat A; Chawla S; Tyagi R; Sudhakar M; Banday AZ; Suri D; Vignesh P; Dhaliwal M; Sharma S; Rikhi R; Saka R; Sharma R; Chatterjee D; Sreedharanunni S; Uppuluri R; Raj R; Singh S
Int Arch Allergy Immunol; 2024; 185(4):370-381. PubMed ID: 38194943
[TBL] [Abstract][Full Text] [Related]
13. Clinical flow cytometric screening of SAP and XIAP expression accurately identifies patients with SH2D1A and XIAP/BIRC4 mutations.
Gifford CE; Weingartner E; Villanueva J; Johnson J; Zhang K; Filipovich AH; Bleesing JJ; Marsh RA
Cytometry B Clin Cytom; 2014 Jul; 86(4):263-71. PubMed ID: 24616127
[TBL] [Abstract][Full Text] [Related]
14. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
15. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
[TBL] [Abstract][Full Text] [Related]
16. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Aguilar C; Latour S
J Clin Immunol; 2015 May; 35(4):331-8. PubMed ID: 25737324
[TBL] [Abstract][Full Text] [Related]
17. Natural killer T cells and X-linked lymphoproliferative syndrome.
Latour S
Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):510-4. PubMed ID: 17989527
[TBL] [Abstract][Full Text] [Related]
18. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
Rigaud S; Fondanèche MC; Lambert N; Pasquier B; Mateo V; Soulas P; Galicier L; Le Deist F; Rieux-Laucat F; Revy P; Fischer A; de Saint Basile G; Latour S
Nature; 2006 Nov; 444(7115):110-4. PubMed ID: 17080092
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.
Yang X; Wada T; Imadome K; Nishida N; Mukai T; Fujiwara M; Kawashima H; Kato F; Fujiwara S; Yachie A; Zhao X; Miyawaki T; Kanegane H
Herpesviridae; 2012 Feb; 3(1):1. PubMed ID: 22325832
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
